Cohort of Patients With Covid-19 Presenting Neurological or Psychiatric Disorders (CoCo-Neurosciences)

计划入组 730 人 · 首次发布于 2020 年 4 月 27 日

Neurosciences Research Repository

计划入组 15,000 人 · 首次发布于 2009 年 3 月 9 日

REALITY MONITORING AND DOPAMINE

计划入组 39 人 · 首次发布于 2023 年 2 月 2 日

RACK1 antagonist (ProMIS Neurosciences)

mTOR Inhibitor(Development Center for Biotechnology)

MSLN ADC(Development Center for Biotechnology)

Prague Psychiatric Center

Czech Republic

MANHATTAN PSYCHIATRIC CENTER

United States

TAOYUAN PSYCHIATRIC CENTER

Taiwan

Addex Therapeutics Publishes Breakthrough Data on mGlu7 Targeting for Anxiety and PTSD Treatment

Vafidemstat Phase IIa Results Published: Shows Promise in Treating Psychiatric Aggression

rTMS Shows Promise in Treating OCD, Especially in Patients with Comorbid Depression